Sensei Biotherapeutics In...
(SNSE)
undefined
undefined%
At close: undefined
0.53
1.11%
After-hours Jan 03, 2025, 05:33 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 571.00K | 1.81M | 685.00K | 209.00K | 73.00K | 44.00K |
| Gross Profit | -571.00K | -1.81M | -685.00K | -209.00K | -73.00K | -44.00K |
| Operating Income | -37.06M | -50.19M | -37.48M | -19.45M | -12.44M | -12.74M |
| Interest Income | 3.62M | 1.78M | 800.00K | 1.69K | 2.26K | n/a |
| Pretax Income | -34.10M | -48.59M | -36.79M | -20.10M | -16.74M | -13.04M |
| Net Income | -34.10M | -48.81M | -37.46M | -20.63M | -19.00M | -13.04M |
| Selling & General & Admin | 18.77M | 19.80M | 15.82M | 7.53M | 4.08M | 4.51M |
| Research & Development | 18.30M | 30.38M | 21.66M | 11.19M | 8.35M | 8.23M |
| Other Expenses | n/a | 1.60M | 688.00K | -649.00K | -1K | 28.00K |
| Operating Expenses | 37.06M | 50.19M | 37.48M | 18.71M | 12.44M | 12.74M |
| Interest Expense | 144.00K | 219.00K | 670.00K | 1.69M | 2.26M | 327.00K |
| Selling & Marketing Expenses | 100.00K | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 37.06M | 50.19M | 37.48M | 18.71M | 12.44M | 12.74M |
| Income Tax | n/a | 219.00K | 670.00K | 529.00K | 2.25M | 299.00K |
| Shares Outstanding (Basic) | 27.95M | 30.70M | 27.71M | 30.59M | 29.33M | 685.16K |
| Shares Outstanding (Diluted) | 27.95M | 30.70M | 27.71M | 30.59M | 29.33M | 685.16K |
| EPS (Basic) | -1.22 | -1.59 | -1.35 | -0.67 | -0.65 | -19.03 |
| EPS (Diluted) | -1.22 | -1.59 | -1.35 | -0.67 | -0.65 | -19.03 |
| EBITDA | -33.39M | -46.56M | -36.80M | -18.50M | -12.36M | -12.70M |
| Depreciation & Amortization | 3.68M | 1.81M | 685.00K | 209.00K | 73.00K | 44.00K |